Hypertension (HTN) is a leading risk factor for cardiovascular
diseases (CVDs) and a major
Nasyrova, Regina F.,
Khasanova, Aiperi K.,
Altynbekov, Kuanysh S.,
Asadullin, Azat R.,
Markina, Ekaterina A.,
Gayduk, Arseny J.,
Shipulin, German A.,
Petrova, Marina M.,
Shnayder, Natalia A. (2022) the search for new therapeutic strategies for a
disease-modifying therapy for treatment-resistant Sch (TRS
ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНААхмадеева, Г.Н.,
Магжанов, Р.В.,
Таюпова, Г.Н.,
Байтимеров, А.Р.,
Хидиятова, И.М.,
Akhmadeeva, G.N.,
Magzhanov, R.V.,
Tayupova, G.N.,
Bajtimerov, A.R.,
Hidijatova, I.M. (2017) in patients with Parkinson’s
disease. Their characteristics and epidemiology, pathogenetic and clinical